These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 19794299)
1. Chromogranin A as a useful neuroendocrine marker in patients with autoimmune Addison's disease. El Ali Z; Fichna M; Piniewska J; Kosowicz J; Grzymisławski M J Endocrinol Invest; 2010 Mar; 33(3):186-91. PubMed ID: 19794299 [TBL] [Abstract][Full Text] [Related]
2. Factors associated with elevated serum chromogranin A levels in patients with autoimmune gastritis. Kalkan Ç; Karakaya F; Soykan İ Turk J Gastroenterol; 2016 Nov; 27(6):515-520. PubMed ID: 27852542 [TBL] [Abstract][Full Text] [Related]
3. Predictive value of gastrin levels for the diagnosis of gastric enterochromaffin-like cell hyperplasia in patients with Hashimoto's thyroiditis. Nicolaou A; Thomas D; Alexandraki KI; Sougioultzis S; Tsolakis AV; Kaltsas G Neuroendocrinology; 2014; 99(2):118-22. PubMed ID: 24776735 [TBL] [Abstract][Full Text] [Related]
4. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy. Sanduleanu S; De Bruïne A; Stridsberg M; Jonkers D; Biemond I; Hameeteman W; Lundqvist G; Stockbrügger RW Eur J Clin Invest; 2001 Sep; 31(9):802-11. PubMed ID: 11589723 [TBL] [Abstract][Full Text] [Related]
5. [Influence of long-term gastric acid suppression therapy on the expression of serum gastrin, chromogranin A, and ghrelin]. Kim BW; Lee BI; Kim HK; Cho YS; Chae HS; Lee HK; Kim HJ; Han SW Korean J Gastroenterol; 2009 Feb; 53(2):84-9. PubMed ID: 19237833 [TBL] [Abstract][Full Text] [Related]
6. Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin-like cell hyperplasia and autoimmune gastritis. Herold Z; Herold M; Nagy P; Patocs A; Doleschall M; Somogyi A J Diabetes Investig; 2020 Jul; 11(4):865-873. PubMed ID: 31883432 [TBL] [Abstract][Full Text] [Related]
7. A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia. Jianu CS; Fossmark R; Syversen U; Hauso Ø; Waldum HL Tumour Biol; 2010 Oct; 31(5):373-80. PubMed ID: 20480408 [TBL] [Abstract][Full Text] [Related]
8. Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia. Hirschowitz BI; Worthington J; Mohnen J; Haber M Aliment Pharmacol Ther; 2007 Sep; 26(6):869-78. PubMed ID: 17767471 [TBL] [Abstract][Full Text] [Related]
9. Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids. Peracchi M; Gebbia C; Basilisco G; Quatrini M; Tarantino C; Vescarelli C; Massironi S; Conte D Eur J Endocrinol; 2005 Mar; 152(3):443-8. PubMed ID: 15757862 [TBL] [Abstract][Full Text] [Related]
10. Are patients with autoimmune thyroid disease and autoimmune gastritis at risk of gastric neuroendocrine neoplasms type 1? Alexandraki KI; Nikolaou A; Thomas D; Syriou V; Korkolopoulou P; Sougioultzis S; Kaltsas G Clin Endocrinol (Oxf); 2014 May; 80(5):685-90. PubMed ID: 24118101 [TBL] [Abstract][Full Text] [Related]
11. [Study on histogenesis of enterochromaffin-like carcinoid in autoimmune atrophic gastritis associated with pernicious anemia]. Macukanović-Golubović L; Katić V; Rancić G; Milenović M; Marjanović G; Golubović Z Vojnosanit Pregl; 2007 Aug; 64(8):543-8. PubMed ID: 17874722 [TBL] [Abstract][Full Text] [Related]
15. Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis. Borch K; Stridsberg M; Burman P; Rehfeld JF Scand J Gastroenterol; 1997 Mar; 32(3):198-202. PubMed ID: 9085454 [TBL] [Abstract][Full Text] [Related]
16. Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study. Sanduleanu S; Stridsberg M; Jonkers D; Hameeteman W; Biemond I; Lundqvist G; Lamers C; Stockbrügger RW Aliment Pharmacol Ther; 1999 Feb; 13(2):145-53. PubMed ID: 10102943 [TBL] [Abstract][Full Text] [Related]
17. The various faces of autoimmune endocrinopathies: non-tumoral hypergastrinemia in a patient with lymphocytic colitis and chronic autoimmune gastritis. Melcescu E; Hogan RB; Brown K; Boyd SA; Abell TL; Koch CA Exp Mol Pathol; 2012 Dec; 93(3):434-40. PubMed ID: 23043903 [TBL] [Abstract][Full Text] [Related]
18. Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis. Boyce M; Moore AR; Sagatun L; Parsons BN; Varro A; Campbell F; Fossmark R; Waldum HL; Pritchard DM Br J Clin Pharmacol; 2017 Mar; 83(3):466-475. PubMed ID: 27704617 [TBL] [Abstract][Full Text] [Related]
19. Gastric carcinoid associated with achlorhydria, hypergastrinemia, and Addison's disease. Bruce TA; Azmy M; Earll JM South Med J; 1988 Dec; 81(12):1595-6. PubMed ID: 3059527 [TBL] [Abstract][Full Text] [Related]
20. Hypergastrinemia as a cause of chromogranin a increase in blood in patients suspected to have neuroendocrine tumor. Kleveland O; Syversen U; Slørdahl K; Waldum HL Digestion; 2001; 64(2):71-4. PubMed ID: 11684818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]